- Home
- SLS vs FORR Comparison
SLS vs FORR Comparison
Compare SLS & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- FORR
- Stock Information
- Founded
- SLS 2012
- FORR 1983
- Country
- SLS United States
- FORR United States
- Employees
- SLS N/A
- FORR N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- FORR Diversified Commercial Services
- Sector
- SLS Health Care
- FORR Consumer Discretionary
- Exchange
- SLS Nasdaq
- FORR Nasdaq
- Market Cap
- SLS 185.3M
- FORR 185.3M
- IPO Year
- SLS N/A
- FORR 1996
- Fundamental
- Price
- SLS $1.85
- FORR $10.22
- Analyst Decision
- SLS Strong Buy
- FORR
- Analyst Count
- SLS 1
- FORR 0
- Target Price
- SLS $7.00
- FORR N/A
- AVG Volume (30 Days)
- SLS 1.9M
- FORR 79.7K
- Earning Date
- SLS 11-12-2025
- FORR 11-04-2025
- Dividend Yield
- SLS N/A
- FORR N/A
- EPS Growth
- SLS N/A
- FORR N/A
- EPS
- SLS N/A
- FORR N/A
- Revenue
- SLS N/A
- FORR $412,103,000.00
- Revenue This Year
- SLS N/A
- FORR N/A
- Revenue Next Year
- SLS N/A
- FORR $1.51
- P/E Ratio
- SLS N/A
- FORR N/A
- Revenue Growth
- SLS N/A
- FORR N/A
- 52 Week Low
- SLS $0.77
- FORR $8.50
- 52 Week High
- SLS $2.27
- FORR $19.74
- Technical
- Relative Strength Index (RSI)
- SLS 52.67
- FORR 57.88
- Support Level
- SLS $1.69
- FORR $9.76
- Resistance Level
- SLS $2.01
- FORR $10.42
- Average True Range (ATR)
- SLS 0.11
- FORR 0.35
- MACD
- SLS 0.00
- FORR 0.06
- Stochastic Oscillator
- SLS 50.00
- FORR 80.39
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.